Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis

Human Brain Mapping

Volumn 35, Issue 3, 2014, Pages 792-809

  Younes, Laurent ^a   Ratnanather, J Tilak ^b   Brown, Timothy ^a   Aylward, Elizabeth ^c,ae,ax   Nopoulos, Peg ^d   Johnson, Hans ^d,g   Magnotta, Vincent A ^d,g   Paulsen, Jane S ^d,g   Margolis, Russell L ^e   Albin, Roger L ^f   Miller, Michael I ^b,av   Ross, Christopher A ^e,j   Wassink, Thomas ^g,bh   Cross, Stephen ^g   Kimble, Mycah ^g   Ryan, Patricia ^g   Epping, Eric A ^g   Chiu, Edmond ^h   Yastrubetskaya, Olga ^h   Preston, Joy ^h   Goh, Anita ^h   Psych, D ^h   Antonopoulos, Stephanie ^h   Loi, Samantha ^h   Chua, Phyllis ^h   Komiti, Angela ^h   Raymond, Lynn ⁱ   Decolongon, Joji ⁱ   Varvaris, Mark ^j   Mallonee, William M ^j   Suter, Greg ^j   Samii, Ali ^c   Macaraeg, Alma ^c   Jones, Randi ^k   Wood Siverio, Cathy ^k   Factor, Stewart A ^k   Testa, Claudia ^k   Barker, Roger A ^l   Mason, Sarah ^l   McCusker, Elizabeth ^m   Griffith, Jane ^m   Loy, Clement ^m   Gunn, David ^m   Orth, Michael ⁿ   Sübmuth, Sigurd ⁿ   Barth, Katrin ⁿ   Trautmann, Sonja ⁿ   Quaid, Kimberly ^o   Wesson, Melissa ^o   Wojcieszek, Joanne ^o   Guttman, Mark ^p   Sheinberg, Alanna ^p   Karmalkar, Irita ^p   Perlman, Susan ^q   Clemente, Brian ^q   Geschwind, Michael D ^r   Kang, Gail ^r   Satris, Gabriela ^s   Warner, Tom ^s   Burrows, Maggie ^t   Rosser, Anne ^t   Price, Kathy ^t   Hunt, Sarah ^t   Marshall, Frederick ^u   Chesire, Amy ^u   Wodarski, Mary ^u   Hickey, Charlyne ^u   Panegyres, Peter ^v   Lee, Joseph ^v   Andrew, Steve ^v   Perlmutter, Joel ^w   Barton, Stacey ^w   Schmidt, Amy ^w   Miedzybrodzka, Zosia ^x,ak   Rae, Daniela ^x   D'Alessandro, Mariella ^x   Craufurd, David ^y   Bek, Judith ^y   Howard, Elizabeth ^y   Mazzoni, Pietro ^z   Marder, Karen ^z   Wasserman, Paula ^z   Kumar, Rajeev ^aa   Erickson, Diane ^aa   Wheelock, Vicki ^ab   Tempkin, Terry ^ab   Kjer, Lisa ^ab   Martin, Wayne ^ac   King, Pamela ^ac   Wieler, Marguerite ^ac   Sran, Satwinder ^ac   Suchowersky, Oksana ^ad   Ahmed, Anwar ^ad   Rao, Stephen ^ad   Reece, Christine ^ad   Bura, Alex ^ad   Mourany, Lyla ^ad   Schulz, Juliet ^ad   Long, Jeffrey D ^g   Montross, Kelsey ^g   Bockholt, Jeremy ^g   Blanchard, Steve ^g   Evans, Ken ^g,af   Matson, Wayne ^ag   Peterson, Asa ^ah   Mills, James A ^g   Vonsattel, Jean Paul ^z   Moskowitz, Carol ^z   Vik, Stacie ^g   Harrington, Deborah ^ab   Castillo, Gabriel ^ab   Morison, Jessica ^ab   Reed, Jason ^ab   Diaz, Michael ^ai   Dobbins, Ian ^ai   Hershey, Tamara ^ai   Foster, Erin ^ai   Moore, Deborah ^ai   Westervelt, Holly ^aj   Davis, Jennifer ^aj   Tremont, Geoff ^aj   David, J ^g   Gehl, Carissa ^ag   Matheson, Kirsty ^ak   Siedlecki, Karen ^al   Walsem, Marleen Van ^am   Elias, Greg ^an   Gover, Mary ^an   Bernier, Rachel ^an   Carlozzi, Noelle ^ao   Duff, Kevin ^ap   Nellie Georgiou Karistianis, ^h   Papp, Kate ^aq   Willia, Janet ^g   Clark, Lee Anna ^g   Downing, Nancy ^g   Harreld, Michelle ^g   Ready, Rebecca ^ar   Vaccarino, Anthony ^af   Farias, Sarah ^ab   MacDonald, Marcy ^as   Gusella, Jim ^as   Myers, Rick ^as   Ross, Christopher ^av   Jones, Kathy ^g   Marietta, Jacquie ^g   Harris, Greg ^g   Kim, Eun Young ^g   Ennis, Greg ^g   Ashburner, John ^at   Potkin, Steve ^au   Toga, Arthur ^aw   Axelson, Eric ^g   Reading, Sarah ^av   Beg, Mirza Faisal ^ay   Helmer, Karl ^as   Lim, Kelvin ⁿ   Lowe, Mark ^ad   Mori, Sasumu ^av   Song, Allen ^az   Turner, Jessica ^au   Beall, Erik ^ad   Koenig, Katherine ^ad   Phillips, Michael ^ad   Zimbelman, Jan ^ad   Fiedorowicz, Jess ^g   Robinson, Robert ^g   Smith, Megan ^g   Beglinger, Leigh ^g   Williams, Janet ^g   Liu, Dawei ^g   Moser, David ^g   Rowe, Kelly ^g   Anderson, Karen ^ba   Groves, Mark ^bb   Rickards, Hugh ^bc   Van Duijn, Eric ^bd   Kim, Ji In ^g   Zhang, Ying ^g   Lu, Wenjing ^g   Stout, Craig ^g   Lourens, Spencer ^g   Nance, Martha ^be   Thompson, Sean ^g   Erwin, Cheryl ^bf   Hughes, Lisa ^bg   Smith, Jim ^g   Zschiegner, Roland ^g   Wyse, Ryan ^g   Wade, Owen ^g   Weston, Derek ^g   Werling Witkoske, Chris ^g   Anderson, Karla ^g   Lichty, Brittany ^g   Davis, Leann ^g   Danzer, Phil ^g   more..

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j Hereditary Neurological Disease Centre   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m WESTMEAD HOSPITAL   (Australia)

ⁿ UNIVERSITY OF ULM   (Germany)

^o INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF TORONTO   (Canada)

^q LOS ANGELES MEDICAL CENTER   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

^s NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^t CARDIFF UNIVERSITY   (United Kingdom)

^u UNIVERSITY OF ROCHESTER   (United States)

^v Graylands Selby Lemnos and Special Care Health Services   (Australia)

^w WASHINGTON UNIVERSITY   (United States)

^x Clinical Genetics Centre   (United Kingdom)

^y UNIVERSITY OF MANCHESTER   (United Kingdom)

^z NewYork Presbyterian Hospital   (United States)

^aa Columbia University Medical Center ^*  (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac UNIVERSITY OF ALBERTA   (Canada)

^ad LERNER RESEARCH INSTITUTE   (United States)

^ae SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^af Ontario Cancer Biomarker Network   (Canada)

^ag VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ah LUND UNIVERSITY   (Sweden)

^ai Washington University Cognitive Science Battery Development   (United States)

^aj BROWN UNIVERSITY   (United States)

^ak UNIVERSITY OF ABERDEEN   (United Kingdom)

^al FORDHAM UNIVERSITY   (United States)

^am EHDN   (United States)

^an RHODE ISLAND HOSPITAL   (United States)

^ao UNIVERSITY OF MICHIGAN   (United States)

^ap UNIVERSITY OF UTAH   (United States)

^aq UNIVERSITY OF CONNECTICUT   (United States)

^ar UNIVERSITY OF MASSACHUSETTS   (United States)

^as MASSACHUSETTS GENERAL HOSPITAL   (United States)

^at Functional Imaging Laboratory   (United Kingdom)

^au UNIVERSITY OF CALIFORNIA   (United States)

^av JOHNS HOPKINS UNIVERSITY   (United States)

^aw UNIVERSITY OF CALIFORNIA   (United States)

^ax Seattle Children's Research Institute   (United States)

^ay SIMON FRASER UNIVERSITY   (Canada)

^az DUKE UNIVERSITY   (United States)

^ba UNIVERSITY OF MARYLAND   (United States)

^bb Och Spine at New York Presbyterian Hospitals   (United States)

^bc QUEEN ELIZABETH PSYCHIATRIC HOSPITAL   (United Kingdom)

^bd LEIDEN UNIVERSITY   (Netherlands)

^be UNIVERSITY OF MINNESOTA   (United States)

^bf Humanities and the Human Spirit   (United States)

^bg UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^bh NONE

more..

Author keywords

Diffeomorphic mapping; Pallidus atrophy; Striatal atrophy; Surface registration; Surface based morphometry

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROBIOLOGY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SUBCORTEX; THALAMUS; ATROPHY; DEVICES; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PRODROMAL SYMPTOM;

ADULT; ATROPHY; BASAL GANGLIA; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS;

EID: 84893816723     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22214     Document Type: Article

References (90)

1. Albin RL, Reiner A, Anderson KD, Dure LSt, Handelin B, Balfour R, Whetsell WO Jr, Penney JB, Young AB (1992): Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 31:425-430.
2. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB (1990): Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 27:357-365.
3. Albin RL, Young AB, Penney JB (1989): The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
4. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A (1990): Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 322:1293-1298.
5. Alexander G, DeLong M, Strick P (1986): I. Parallel organization of cuntionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381.
6. Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM (2003): Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2:79-88.
7. Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS (2011): Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82:405-410.
8. Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA (2004): Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63:66-72.
9. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003): Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211.
10. Brown TB, Bogush AI, Ehrlich ME (2008): Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse. Hum Mol Genet 17:3095-3104.
11. Cavada C, Goldman-Rakic PS (1991): Topographic segregation of corticostriatal projections from posterior parietal subdivisions in the macaque monkey. Neuroscience 42:683-696.
12. Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI (1998): Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci USA 95:11406-11411.
13. Csernansky JG, Wang L, Jones D, Rastogi-Cruz D, Posener JA, Heydebrand G, Miller JP, Miller MI (2002): Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am J Psychiat 159:2000-2006.
14. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI (2000): Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Neurology 55:1636-1643.
15. Cudkowicz M, Kowall NW (1990): Degeneration of pyramidal projection neurons in Huntingtons-disease cortex. Ann Neurol 27:200-204.
16. de la Monte SM, Vonsattel JP, Richardson EP Jr (1988): Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 47:516-525.
17. Deng Y, Albin R, Penney J, Young A, Anderson K, Reiner A (2004): Differential loss of striatal projection systems in Huntington's disease: A quantitative immunohistochemical study. J Chem Neuroanat 27:143-164.
18. Douaud G, Behrens TE, Poupon C, Cointepas Y, Jbabdi S, Gaura V, Golestani N, Krystkowiak P, Verny C, Damier P, Bachoud-Levi AC, Hantraye P, Remy P (2009): In vivo evidence for the selective subcortical degeneration in Huntington's disease. NeuroImage 46:958-966.
19. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P (2006): Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. NeuroImage 32:1562-1575.
20. Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL (2004): In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989-995.
21. Ferrante R, Beal MF, Kowall NW, Richardson EP Jr, Martin JB (1987a): Sparing of acetylcholinesterase-containing striatal neurons in Huntington's diseaseBrain Res 411:162-166.
22. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB (1985): Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-563.
23. Ferrante RJ, Kowall NW, Richardson EP Jr, Bird ED, Martin JB (1986): Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci Lett 71:283-288.
24. Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB (1987b): Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46:12-27.
25. Grenander U, Miller MI (2007): Pattern Theory: From Representation to Inference. New York:Oxford University Press.xii, 596 p.
26. Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, Heintz N, Yang XW (2005): Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433-444.
27. Haber SN, Knutson B (2009): The reward circuit: Linking primate anatomy and human imaging. Neuropsychopharmacology 35:4-26.
28. Harper P, Lim C, Craufurd D (2000): Ten years of presymptomatic testing for Huntington's disease: The experience of the UK Huntington's disease Prediction Consortium. J Med Genet 37:567-571.
29. HD Collaborative Group (1993): A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
30. Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991): Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261.
31. Hobbs NZ, Henley SM, Ridgway GR, Wild EJ, Barker RA, Scahill RI, Barnes J, Fox NC, Tabrizi SJ (2010): The progression of regional atrophy in premanifest and early Huntington's disease: A longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 81:756-763.
32. Hobbs NZ, Henley SM, Wild EJ, Leung KK, Frost C, Barker RA, Scahill RI, Barnes J, Tabrizi SJ, Fox NC (2009): Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease. NeuroImage 47:1659-1665.
33. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC (2008): Huntington's disease: From pathology and genetics to potential therapies. Biochem J 412:191-209.
34. Jernigan TL, Salmon DP, Butters N, Hesselink JR (1991): Cerebral Structure on Mri.2. Specific Changes in Alzheimers and Huntingtons Diseases. Biol Psychiat 29:68-81.
35. Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ane MN, van der Grond J, Middelkoop HA, Roos RA (2008): Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J Neurol 255:1785-1791.
36. Kemp J, Powell T (1970): The cortico-striate projection in the monkey. Brain 93:525-546.
37. Kunzle H (1975): Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study inMacaca fascicularis. Brain Res 88:195-209.
38. Kunzle H (1977): Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Exp Brain Res 30:481-492.
39. Langbehn DR, Hayden MR, Paulsen JS (2010): CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet 153B:397-408.
40. Lange H, Thörner G, Hopf A, Schröder K (1976): Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28:401-425.
41. Ma J, Miller M, Younes L (2010): A bayesian generative model for surface template estimation. Int J Biomed Imaging 2010:14.
42. Marrakchi-Kacem L, Delmaire C, Tucholka A, Roca P, Guevara P, Poupon F, Yelnik J, Durr A, Mangin JF, Lehericy S, Poupon C (2010): Analysis of the striato-thalamo-cortical connectivity on the cortical surface to infer biomarkers of Huntington's disease. Med Image Comput Comput Assist Interv 13:217-224.
43. Morrison P, Harding-Lester S, Bradley A (2011): Uptake of Huntington disease predictive testing in a complete population. Clin Genet 80:281-286.
44. Mumford D, Desolneux A (2010): Pattern Theory: The Stochastic Analysis of Real-world signals. Natick:A. K. Peters.375 p.
45. Nichols T, Hayasaka S (2003): Controlling the familywise error rate in functional neuroimaging: A comparative review. Stat Methods Med Res 12:419-446.
46. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS (2010): Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 40:544-554.
47. Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P (2012): Measures of growth in children at risk for Huntington disease. Neurology 79:668-674.
48. Nopoulos PC, Aylward EH, Ross CA, Mills JA, Langbehn DR, Johnson HJ, Magnotta VA, Pierson RK, Beglinger LJ, Nance MA, Barker RA, Paulsen JS (2011): Smaller intracranial volume in prodromal Huntington's disease: Evidence for abnormal neurodevelopment. Brain 134:137-42.
49. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006): Brain structure in preclinical Huntington's disease. Biol Psychiatry 59:57-63.
50. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M (2008): Detection of Huntington's disease decades before diagnosis: The PREDICT-HD study. J Neurol Neurosurg Psychiatry 79:874-880.
51. Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M (2010): Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201-207.
52. Paulson H, Albin R (2010): Huntington's disease: Clinical features and routes to therapy. In: Lo D, Hughes R, editors. Neurobiology of Huntington's disease: applications to drug discovery, CRC press, Boca Raton (FL), Chapter 1.
53. Pierson R, Johnson H, Harris G, Keefe H, Paulsen JS, Andreasen NC, Magnotta VA (2011): Fully automated analysis using BRAINS: AutoWorkup. NeuroImage 54:328-336.
54. Qiu A, Adler M, Crocetti D, Miller MI, Mostofsky SH (2010): Basal ganglia shapes predict social, communication, and motor dysfunctions in boys with autism spectrum disorder. J Am Acad Child AdolescPsychiatry 49:539-551.
55. Qiu A, Crocetti D, Adler M, Mahone EM, Denckla MB, Miller MI, Mostofsky SH (2009a): Basal ganglia volume and shape in children with attention deficit hyperactivity disorder. Am J Psychiatry 166:74-82.
56. Qiu A, Fennema-Notestine C, Dale AM, Miller MI (2009b): Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease. NeuroImage 45:656-661.
57. Qiu A, Wang L, Younes L, Harms MP, Ratnanather JT, Miller MI, Csernansky JG (2009c): Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non-psychotic siblings. NeuroImage 47:1221-1229.
58. Qiu A, Younes L, Miller MI, Csernansky JG (2008): Parallel transport in diffeomorphisms distinguishes the time-dependent pattern of hippocampal surface deformation due to healthy aging and the dementia of the Alzheimer's type. NeuroImage 40:68-76.
59. Qiu A, Younes L, Wang L, Ratnanather JT, Gillepsie SK, Kaplan G, Csernansky J, Miller MI (2007): Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophrenia. NeuroImage 37:821-833.
60. Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, Kash LM, Ghaffari M, Chase GA, Kazazian HH, Brandt J, Folstein SE, Ross CA (1995): Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57:593-602.
61. Rangarajan A, Chui H, Bookstein F (1997): The softassign procrustes matching algorithm.Springer. p29-42.
62. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988): Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci USA 85:5733.
63. Richfield EK, Herkenham M (1994): Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36:577-584.
64. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P (1995): Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38:852-861.
65. Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM (2008): Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 131:1057-1068.
66. Ross CA, Tabrizi SJ (2011): Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurol 10:83-98.
67. Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel JP, DiFiglia M (1995): Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64:397-404.
68. Selemon L, Goldman-Rakic P (1985): Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 5:776-794.
69. Sotrel A, Williams RS, Kaufmann WE, Myers RH (1993): Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: A quantitative Golgi study. Neurology 43:2088-2096.
70. Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A (2009): Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease. CNS Neurosci Ther 15:1-11.
71. Sritharan A, Egan GF, Johnston L, Horne M, Bradshaw JL, Bohanna I, Asadi H, Cunnington R, Churchyard AJ, Chua P, Farrow M, Georgiou-Karistianis N (2010): A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 81:257-262.
72. Stoffers D, Sheldon S, Kuperman J, Goldstein J, Corey-Bloom J, Aron A (2010): Contrasting gray and white matter changes in preclinical Huntington disease: An MRI study. Neurology 74:1208.
73. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RAC, Durr A, Craufurd D, and Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC (2009): Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol 8:791-801.
74. Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, Frost C, Langbehn DR, the TRACK-HD investigators (2012): Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol 11:42-53.
75. Tabrizi SJ, Scahill RI, Durr A, Roos RAC, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, Stout JC, the TRACK-HD investigators (2011): Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurol 10:31-42.
76. Thompson PM, Hayashi KM, de Zubicaray GI, Janke AL, Rose SE, Semple J, Hong MS, Herman DH, Gravano D, Doddrell DM, Toga AW (2004): Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22:1754-1766.
77. Vaillant M, Glaunès J (2005): Surface matching via Currents. In: Christensen G, Sonka M, Editors. Information Processing in Medical Imaging. Lecture notes in computer sciences, New York:Springer-Verlag. pp 381-392.
78. van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA (2011): Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy-results from the TRACK-HD study. J Neurol Sci 307:60-68.
79. Vandenberghe W, Demaerel P, Dom R, Maes F (2009): Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 256:109-114.
80. Vonsattel J, Myers R, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985): Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559.
81. Vonsattel JPG, Lianski M (1997): Huntington's disease. In: Esiri MM, Lee VM-Y, Trojanowski JQ, Editors. The Neuropathology of Dementia, Cambridge University Press, p219-240.
82. Wang L, Beg M, Ratnanather J, Ceritoglu C, Younes L, Morris J.Miller M (2007): Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE T Med Imaging 26:462-470.
83. Warby S, Graham R, Hayden M (2010): Huntington Disease. US National Library of Medicine Bookshelf (online). Available at: http://www.ncbi.nlm.nih.gov/books/NBK1305 (Accessed May 20, 2011).
84. Weaver KE, Richards TL, Liang O, Laurino MY, Samil A, Aylward EH (2009): Longitudinal diffusion tensor imaging in Huntington's Disease. Exp Neurol 216:525-529.
85. Yeterian E, Pandya D (1995): Corticostriatal connections of extrastriate visual areas in rhesus monkeys. J Comp Neurol 352:436-457.
86. Yeterian EH, Van Hoesen GW (1978): Cortico-striate projections in the rhesus monkey: The organization of certain cortico-caudate connections. Brain Res 139:43-63.
87. Yeterian EH, Pandya DN (1993): Striatal connections of the parietal association cortices in rhesus monkeys. J Comp Neurol 332:175-197.
88. Younes L (2010): Shapes and Diffeomorphisms. New York:Springer.
89. Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS; PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2011): Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156B:751-763.
90. Zuccato C, Cattaneo E (2009): Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311-322.